Home › Funds › North Growth Management Ltd. › ZYME
North Growth Management Ltd. position in ZYME
ZYMEWORKS INC · Health Care
North Growth Management Ltd. reported holding 47,000 shares of ZYME (ZYMEWORKS INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. North Growth Management Ltd. has disclosed ZYME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How North Growth Management Ltd.'s ZYME position evolved
North Growth Management Ltd. first disclosed a stake in ZYME in Q3 2023 at 97,000 shares (US$614K). The position peaked in Q4 2024 at 97,000 shares, worth US$1.4M. Across 13 filings, North Growth Management Ltd. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 47,000 shares valued at US$1.2M — an increase of 1,000 shares quarter over quarter.. Notable position changes include a 45% trim in Q4 2025 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 97.00K | $614.00K | New |
| Q4 2023 | 97.00K | $1.01M | Hold |
| Q1 2024 | 97.00K | $1.02M | Hold |
| Q2 2024 | 97.00K | $825.00K | Hold |
| Q3 2024 | 97.00K | $1.22M | Hold |
| Q4 2024 | 97.00K | $1.42M | Hold |
| Q1 2025 | 97.00K | $1.15M | Hold |
| Q2 2025 | 97.00K | $1.22M | Hold |
| Q3 2025 | 82.00K | $1.41M | Reduce |
| Q4 2025 | 45.00K | $1.18M | Reduce |
| Q1 2026 | 46.00K | $1.14M | Add |
| Q2 2026 | 46.00K | $1.20M | Hold |
| Q3 2026 | 47.00K | $1.24M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZYME and 13F data
ZYME (ZYMEWORKS INC) is a Health Care company. 28 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), PERCEPTIVE ADVISORS LLC (US$109.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZYME
- EcoR1 Capital, LLC 22.97M sh · $600.45M · Q2 2026
- Rubric Capital Management LP 7.00M sh · $182.98M · Q2 2026
- PERCEPTIVE ADVISORS LLC 4.18M sh · $109.34M · Q2 2026
- BVF INC/IL 3.65M sh · $95.39M · Q2 2026
- Nextech Invest Ltd. 1.11M sh · $29.12M · Q2 2026
- Prosight Management, LP 674.43K sh · $17.63M · Q2 2026
- Redmile Group, LLC 491.65K sh · $12.85M · Q2 2026
More on North Growth Management Ltd.
FAQ
How long has North Growth Management Ltd. held ZYME?
North Growth Management Ltd. has disclosed ZYME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is North Growth Management Ltd.'s current position in ZYME?
As of Q3 2026, North Growth Management Ltd. holds 47.00K shares of ZYME (ZYMEWORKS INC), valued at $1.24M, representing 0.17% of its reported portfolio and ranking #46.
Has North Growth Management Ltd. been buying or selling ZYME?
In the latest 13F filing (Q3 2026), North Growth Management Ltd. increased its position in ZYME. The position peaked in Q4 2024 at 97.00K shares.
Which other funds hold ZYME?
Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, PERCEPTIVE ADVISORS LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.